Biotech

All Articles

AvenCell bags $112M to snap 'switchable' CAR-Ts in the facility

.AvenCell Therapies has actually secured $112 million in series B funds as the Novo Holdings-backed ...

China- located biotech plannings ph. 3 after viewing midstage eye information

.China-based Minghui Pharmaceutical has actually linked its thyroid eye health condition procedure t...

Sangamo slashes time to market for Fabry genetics treatment as FDA agrees to sped up authorization plan

.Sangamo Therapeutics has actually pinpointed a shortcut to market for its own Fabry illness candida...

Otsuka's kidney disease medicine improves UPCR levels in ph. 3 trial

.Otsuka Pharmaceutical's renal illness medicine has struck the main endpoint of a period 3 trial thr...

Roche throws out $120M tau prospect, coming back legal rights to UCB

.Roche has actually sent back the rights to UCB's anti-tau antitoxin bepranemab, ignoring a $120 mil...

Editas builds up in vivo method through $238M Genenvant contract

.Editas Medicines has signed a $238 million biobucks contract to mix Genevant Science's lipid nanopa...

Combo end results, Vicodin overlook and also outstanding safety

.Vertex has stated phase 3 data on its own near-approval discomfort drug applicant suzetrigine, clar...

Angelini markers $360M biobucks treaty for ph. 1 mind ailment medication

.Italy's Angelini Pharma has authorized a $360 thousand biobucks treaty centered on a stage 1-stage ...

Sage gives up one-half of R&ampD team as well as shakes up C-suite once again

.Sage Therapies' most recent try to shrink its pipe as well as labor force will observe a 3rd of the...

With period 1 data, Atmosphere possesses an eye on early-stage sac cancer cells

.With its own lead applicant in a stage 3 trial for an unusual eye cancer, Aura Biosciences is tryin...